Tirzepatide to semaglutide The most common switch
Improvement of muscle mass is highly desirable in patients with diabetes, who are more prone to sarcopenia conditions
Semaglutide helps lower blood sugar by mimicking a hormone thats naturally secreted when food is consumed, says Ariana Chao, assistant professor at the University of Pennsylvania School of Nursing and medical director at the schools Center for Weight and Eating Disorders
Tirzepatide (Mounjaro/Zepbound) targets two GLP-1 and GIP making it potentially more effective for both weight loss and blood sugar control
Ozempics packaging also warns of more potentially severe side effects such as pancreatitis, changes in vision, kidney failure and the possibility of developing thyroid tumors
A provider must determine whether Tirzepatide is clinically appropriate based on medical history, goals, and safety factors